![Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting | Gene Therapy Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting | Gene Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.gt.3301493/MediaObjects/41434_2001_Article_BF3301493_Fig1_HTML.jpg)
Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting | Gene Therapy
![Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism. - Abstract - Europe PMC Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6071274/bin/cancers-10-00240-g001.jpg)
Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism. - Abstract - Europe PMC
![Determination of Structural Principles Underlying Three Different Modes of Lymphocytic Choriomeningitis Virus Escape from CTL Recognition | The Journal of Immunology Determination of Structural Principles Underlying Three Different Modes of Lymphocytic Choriomeningitis Virus Escape from CTL Recognition | The Journal of Immunology](https://www.jimmunol.org/content/jimmunol/172/9/5504/F1.large.jpg)
Determination of Structural Principles Underlying Three Different Modes of Lymphocytic Choriomeningitis Virus Escape from CTL Recognition | The Journal of Immunology
![Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting | Gene Therapy Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting | Gene Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsj.gt.3301493/MediaObjects/41434_2001_Article_BF3301493_Fig4_HTML.jpg)
Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting | Gene Therapy
The Newly Discovered Cytokine IL-34 Is Expressed in Gingival Fibroblasts, Shows Enhanced Expression by Pro-Inflammatory Cytokines, and Stimulates Osteoclast Differentiation
The Newly Discovered Cytokine IL-34 Is Expressed in Gingival Fibroblasts, Shows Enhanced Expression by Pro-Inflammatory Cytokines, and Stimulates Osteoclast Differentiation
The Newly Discovered Cytokine IL-34 Is Expressed in Gingival Fibroblasts, Shows Enhanced Expression by Pro-Inflammatory Cytokines, and Stimulates Osteoclast Differentiation
The Newly Discovered Cytokine IL-34 Is Expressed in Gingival Fibroblasts, Shows Enhanced Expression by Pro-Inflammatory Cytokines, and Stimulates Osteoclast Differentiation
Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma
Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma
Understanding the pathophysiological actions of tau oligomers : a critical review of current electrophysiological methods - WRAP: Warwick Research Archive Portal
Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma
Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma
![Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism. - Abstract - Europe PMC Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6071274/bin/cancers-10-00240-g002.jpg)